SCHEMBL8465212

SCHEMBL8465212

Fc1ccc2nc(CCl)sc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.56
AXL P30530 1/20 0.56
ALDH1A1 P00352 4/20 0.51
MAPT P10636 4/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
LMNA P02545 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
PKM P14618 1/20 0.51
ALOX12 P18054 1/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 6/20 0.48
RAB9A P51151 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
APP P05067 6/20 0.47
PDPK1 O15530 1/20 0.45
DYRK1A Q13627 1/20 0.45
HTT P42858 2/20 0.44
MCL1 Q07820 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8461410 0.86 LOXL2 (0.47) GFERAXLKMT2AMAPK1NPC1
Phosphine SCHEMBL9339078 0.84 LOXL2 (0.46) GFERAXLKMT2AMAPK1NPC1
SCHEMBL6630285 0.82 NPC1 (0.63) GFERAXLALDH1A1MAPTKDM4E
SCHEMBL7222770 0.82 GFER (0.56) GFERAXLALDH1A1MAPTKDM4E
SCHEMBL7547176 0.82 GFER (0.56) GFERAXLALDH1A1MAPTKDM4E
SCHEMBL1729400 0.82 GFER (0.61) GFERAXLALDH1A1MAPTKDM4E
SCHEMBL4390136 0.80 NPC1 (0.53) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL5968511 0.79 GFER (0.57) GFERAXLALDH1A1MAPTKDM4E
SCHEMBL29184144 0.79 RAB9A (0.47) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL26426430 0.79 RAB9A (0.56) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998451-A LIPOXYGENASE INHIBITORS PFIZER INC (US) 1999-12-07 US disclosed
EP-0533695-B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY PFIZER (US) 1994-10-05 EP disclosed
US-5322847-A Inhibit platelet activating factor, block leukotriene D4 receptors PFIZER INC. (US) 1994-06-21 US disclosed
CN-1021823-C Substituted chroman compounds for treatment of asthma, arthritis and the like PFIZER (US) 1993-08-18 CN disclosed
EP-0313295-B1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA, ARTHRITIS AND RELATED DISEASES PFIZER INC. (US) 1993-07-28 EP disclosed
EP-0533695-A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY. PFIZER (US) 1993-03-31 EP disclosed
CN-1064864-A The tetraline that replaces and the preparation method of allied compound PFIZER (US) 1992-09-30 CN disclosed
CN-1063489-A Substituted benzotetrahydropyridines and related compounds PFIZER (US) 1992-08-12 CN disclosed
WO-1991017163-A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY PFIZER INC. (US) 1991-11-14 WO disclosed
US-5059609-A Lipoxygenase inhibitors; leukotriene receptor blockers; psoriasis; antiulcer agents and myocardial infarctions PFIZER INC. (US) 1991-10-22 US disclosed
CN-1032659-A Substituted tetralins, chromans and like compounds for the treatment of asthma, arthritis and like diseases PFIZER (US) 1989-05-03 CN disclosed
EP-0313295-A2 Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1989-04-26 EP disclosed